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CUTA, a gene that can complement a transcriptional 
mutation of the major histocompatibiiity complex 
(MHC) class Ii genes, was tested for its ability to func- 
tion as a coactivator. CflTA cDNA clones isolated 
showed alternative RNA splicing, but only one splice 
site combination was able to restore class ii MHC gene 
expression. DNA-mediated transfection experiments 
showed that CIITA directs its activity through the X 
box element; the presence of CIITA leads to the forma- 
tion of a higher order complex at the X box region; 
and CIITA contains a potent activation domain. These 
findings support the hypothesis that CIITA directly in- 
teracts with the MHCciass II-specific transcription fac- 
tors and is required for expression. 
Introduction 
The three isotypes of the class II human major histocom- 
patibilitycompiex(MHC), HLA-DR, HLA-DQ, and HLA-DP, 
function in the presentation of processed antigenic pep- 
tides to helper T lymphocytes (reviewed by Unanue et al., 
1989). The expression of class II MHC gene products is 
limited mostly to those cells designed for antigen presenta- 
tion, which include macrophages, 6 cells, and thymic epi- 
thelial cells. Class II MHC expression, an early marker of 
the B lymphocyte lineage, increases through maturation 
and finally is turned off in the terminal stage plasma ceil 
(Noelle et al., 1988; Glimcher and Kara, 1992). A variety 
of external signals, of which interferon-y (IFNy) is the most 
potent, can induce class Ii MHC gene expression in most 
cell types, rendering those cells immunocompetent (Pober 
et al., 1983; Glimcher and Kara, 1992; Boss and Strom- 
inger, 1988; Basta et al., 1987). Class II MHC expression 
in nonimmune cells could have the benefit of aiding an 
acute immune response. However, prolonged or aber- 
rantly expressed MHC proteins could potentially result in 
the activation or continuance of autoimmune responses 
(Guardiola and Maffei, 1993). In contrast, the lackof class 
II MHC gene transcription in patients exhibiting congenital 
class Ii immunodeficiency or bare lymphocyte syndrome 
(bls) results in their inability to mount a specific immune 
response to soluble antigens (dePrevai et al., 1985; Gris- 
celli et al., 1989). Thus, the regulation of class II MHC 
gene products is essential for a carefully controlled im- 
mune response. 
A series of conserved upstream sequences has been 
shown to be responsible for controlling constitutive 
pression of class ii genes in B ceils and induction by II 
in a variety of ceil types (reviewed by Giimcher and K 
1992; Benoist and Mathis, 1990). The conserved eiemc 
have been termed the W, X, and Y boxes. The X I 
which has been subdivided into the Xl and X2 boxe 
sufficient for B ceil-specific expression (Sloan and Bl 
1988; Sloan et al., 1992; Tsang et al., 1988) and is requ 
for IFNy induction (Boss and Strominger, 1988; Basi 
al., 1988; Tsang et al., 1988, 1990; Sloan et al., 19 
The requirement for X box activity in controlling clal 
expression has been further highlighted by the failur 
this element to direct expression in blsderived and o 
class ii transcriptional mutant ceil lines (Hasegawa ei 
1993; Riley and Boss, 1993). Of the family of factors 
can interact with the Xl box, RFX is likely to be the cri 
factor for class Ii MHC gene expression, as the abs6 
of RFX binding activity in B ceil nuclear extracts der 
from bls patients of two compiementation groups c( 
lates with the lack of class II expression (Reith et al., 1’ 
Herrero Sanchez et al., 1992; Hasegawa et al., 1E 
Three bls compiementation groups, A, B, and C, t 
been clearly defined (Benichou and Strominger, 1 
Seidl et al., 1992). The fact that two compiementc 
groups (B and C) lack RFX activity (Herrero Sancho 
al., 1992; Hasegawa et al., 1993) suggests that RFX 
be muitimeric in structure, with each complementi 
group lacking acritical subunit (Durand et al., 1994). X 
(Hasegawa and Boss, 1991) and hXBP-1 (Liou et al., 1 
Ono et al., 1991) have been shown to interact specifil 
with the TREICRE-like X2 box element and are expre! 
in 6 cells. The Y box element, an inverted CCAAl 
quence, binds the factor NF-Y (Hooft van Huijsduijnt 
al., 1990) and functions to augment X box-directec 
pression (Hasegawa et al., 1993; Riley and Boss, l! 
W box elements and factors are the least conserved 
characterized. The W box appears to be composed of 
erai subelements, which include a Z or S box (Tsar 
al., 1990) and a J box (Sugawara et al., 1991). Th 
box provides a 2- to 4-fold enhancement to X box-d1 
reporter genes expressed in B ceils and is require1 
IFNy induction (Hasegawa et al., 1993; Sloan et al., 1 
Tsang et al., 1988, 1990; Cogsweli et al., 1991; Bas 
al., 1988). 
Among the class II bls and in vitro-derived tranz 
tional mutants, those of compiementation group A 
perhaps the most interesting. RJ2.2.5, a ceil line de 
by mutagenesis from the Burkitt’s lymphoma B cei 
Raji, was the first member of this group (Accolla, 1’ 
Like other bls cell lines, RJ2.2.5 ceils could not exf 
a reporter gene driven by an X box containing pron 
(Hasegawa et al., 1993). Nuclear extracts prepared 
RJ2.2.5 contained RFX, XPBP, and NF-Y binding actb 
(Hasegawa et al., 1993; Herrero Sanchez et al., 1 
Furthermore, invivodimethylsuiphatefootprintingde 
strated that the conserved promoter sequences of RJ 
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Figure 1. RT-PCR of Class II MHC-Positive B Cell RNA Shows Multi- 
ple Products 
Cytoplasmic RNA (1 ug) isolated from Raji cells was subjected to RT- 
PCR. Reactions were carried out with (plus) or without (minus) reverse 
transcriptase. All reactions contained a common 3’ amplification 
primer specific for CllTA at base pair 801. The 5’ primer in lanes 1 
and 2, which amplified the sequence between base pairs 104 and 801 
of CIITA, showed two major bands of approximately 700 and 580 bp 
in size, as well as minor bands. A clone CMTA-1,23/C//TA-2.7 l-specific 
primer (5’ GTGTGCAGGGCAGGTGGGCTG) used in lanes 3 and 4 
amplified a 410 bp fragment of predicted size from the two cDNA 
clones, A CIITA-2.1 I-specific primer (Y-GGTGTGCAGGGCAGGT- 
GGGC) used in lanes 5 and 8 amplified a 880 bp fragment identical 
in size to the CIITA-2.7 1 cDNA. 
were identical in protein occupancy to the promoter of the 
wild-type cell line Raji (Kara and Glimcher, 1991). Thus, 
by all appearances, the defect in RJ2.2.5 was not directly 
in the ability of proteins to bind to the conserved elements. 
Aside from the failure of the X box to function in this cell 
line, a clue that a critical element was defective in RJ2.2.5 
was recently described in experiments in which a GAL4- 
VP1 6 activator was used to probe interactions at a HLA- 
DRA promoter that had a GAL4 DNA-binding site inserted 
upstream of the class II-conserved elements (Riley and 
Boss, 1993). GAL4-VP16-mediated expression was pre- 
vented in the wild-type Raji cells but not in RJ2.2.5, sug- 
gesting that a more stable or higher order complex formed 
in the wild-type cell but not in the mutant. The factor re- 
sponsible for this effect was termed the RJ coactivator 
and it was hypothesized to interact with the class II-bound 
factors. 
Recently, Steimle et al. (1993) cloned the defective gene 
in RJ2.2.5 by functional complementation and termed the 
gene the class II transactivator (CIITA). C//TA was able to 
complement all membersof complementation group A but 
not members of the other complementation groups. CIITA 
expression is induced by IFNy in a time course that pre- 
cedes MHC class II expression, suggesting that the induc- 
tion of class II genes by IFNy functions through the expres- 
sion of C//TA (Steimle et al., 1994; Chin et al., 1994; Chang 
et al., 1994). CMTA expression can induce class II MHC 
genes in class II-negative plasmocytes, suggesting that 
CIITA may be a limiting component for class II MHC gene 
regulation (Silacci et al., 1994). How CIITA functions is 
therefore a critical issue for understanding class II MHC 
gene expression. In this report, we provide evidence that 
CIITA is the RJ coactivator. Cotransfection of C//TA cDNA 
clones with class II MHC-driven reporter constructions 
demonstrated that the minimal requirements for MHC 
clas8 II expression in B cells are CIITA, the Xl and X2 
boxes, and their respective DNA-binding factors. Using 
GAL4-CIITA fusions, a potent transcriptional activation 
domain was identified in the N terminus of CIITA that func- 
tions in both human B cells and in yeast. Lastly, in 
agreement with our previous studies (Riley and Boss, 
1993), C//TA expression in RJ2.2.5 creates a complex that 
prevents GAL4-VP16-mediated expression of an X box- 
driven reporter construct. Together, these data are consis- 
tent with the hypothesis that CIITA interacts with the X box 
DNA-binding proteins and provides the signal to activate 
MHC class II gene transcription. 
Results 
Isolation of C//TA cDNA Clones 
To begin to study the mechanism by which CIITA functions 
in controlling class II MHC genes, the expression pattern 
of C//TA was investigated by reverse transcriptase-poly- 
merase chain reaction (RT-PCR) analysis of the class II- 
positive B lymphocyte cell line Raji. Using PCR primers 
corresponding to the 5’ quarter of the cDNA, two major 
and several minor RT-PCR products were detected in Raji 
cells (Figure 1, lane 1). The multiple products suggested 
that there were several forms of the CNTA transcript ex- 
pressed in class II-positive B cells. To investigate further 
the nature of these transcripts, cDNA clones correspond- 
ing to these multiple forms were obtained by hybridization 
screening of an oriP-based plasmid expression B cell 
cDNA library (provided by Dr. M. Buckwald, Toronto; 
Strathdee et al., 1992). The screening resulted in the isola- 
tion of four clones (CIITA-8, CIITA-2.11, CIITA-10, and 
CIITA-7.23) that were full-length and different from the 
clone reported by Steimle et al. (1993; Figure 2). The 
Steimle et al. (1993) cDNA will be referred to here as CIITA. 
Base pair and amino acid residue numbering will be de- 
noted according to the published CllTA sequence. 
DNA sequence analysis showed that CIITA-8 was identi- 
cal in coding sequence to CUTA but had an additional 20 
bp of 5’ and 1.6 kb of 3’ untranslated sequences. CIITA-8 
should therefore produce a wild-type protein. The re- 
maining clones contained a variety of coding region inser- 
tions, deletions, and additional sequences at their S’ends 
(Figure 2). CIITA-2.71 contained an insertion of 479 bp 
within the coding sequence beginning at CllTA base pair 
position 596. DNA sequence analysis indicated that this 
sequence contained stop codons in all reading frames. 
Consensus splice sites were present at the junctions of the 
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insert, suggesting that this cDNA may contain an intron. 
C//TA-2.17 also contained an additional 30 bp of sequence 
at the 3’ end. CIITA-1.23 contained the 3’ 248 bp of the 
inserted DNA found in the coding region of WTA-2.77. 
This insert was also found at base pair position 596 and at 
least one stop codon could be found in all reading frames. 
CIITA-70 had two major differences from CIITA. The first 
was again at position 596, where an in-frame deletion re- 
moved the DNA between base pairs 596 and 744, resulting 
in a loss of 49 aa. This deletion removes a portion of a 
serine-, proline-, and threonine-rich region. The second 
change was at base pair position 2626, where the CllTA 
sequence ends and 779 bp of unique cDNA begins. A 
stop codon is located 138 bp downstream of this unique 
3’ sequence, resulting in a truncated protein of 884 aa 
instead of 1130 aa. CIITA-70 also contains a 3 bp insertion 
at base pair 473 that results in a lysine to isoleucine change 
at residue 120 and adds a glutamic acid. 
CUTA Splice Variants Are Present 
in Wild-Type B Cells 
The identification of alternate transcripts by RT-PCR and 
the isolation of alternatively spliced C//TA cDNA clones 
questioned whether the original C//TA cDNA represented 
the major product of the gene. To examine the C//TA RNA 
products contained in B cells, RT-PCR was again carried 
out to amplify the region surrounding base pair 596, which 
displayed alternative splicing. However, in this experi- 
ment, one of the primers was radiolabeled to allow se- 
quencing. The pattern was the same as in Figure 1, lane 
1. Chemical sequence analysis of the amplified products 
showed that the upper band corresponded to the se- 
quence in CIITA and CIITA8, and the lower band to the 
alternative splice that was found in CUTA-70. Thus, both 
the original WTA sequence and the alternatively spliced 
form displayed by CIITA-70 are found in B cells. Bands 
corresponding to CIITA-2.7 1 and CllTA-7.23 were not ob- 
served,,indicating that these transcripts are rare in abun- 
dance. C//TA-7.23 and CIITA-2.17 transcripts could, how- 
ever, be detected by RT-PCR if either C//TA-7.23- or 
CIITA-2.7 l-specific primers with CIITA-specific primers 
are used (see Figure 1, lanes 3 and 5, respectively). 
CIITA-8, CIITA.2.11, and CUTA-1.23 Can Revert the 
Class II-Negative Phenotype of RJ2.2.5 
The key property of C//TA was its ability to complement 
functionally the transcriptional defect in RJ2.2.5 cells. To 
Figure 2. Schematic Diagram of Altern 
CIITA cDNA Clones 
Full-length cDNA clones (4) are shown for 
pa&on with the CIITA clone isolated by 5th 
et al. (1993). Shaded boxes indicate codin 
quences identical to CIITA; open and cl 
boxes indicate sequence insertions specif 
CIITA-2.11 or CIITA-1.23, respectively. 
striped box represents the unique 3’codir 
gion of CUTA-10, and shaded bars repro 
3’ UTRs unique to their respective clone 
determine whether the alternatively processed ct 
clones could revert the RJ2.2.5 defect, CIITA-c[ 
clones were transfected into RJ2.2.5 cells, stable p 
were isolated, and the cells tested for surface class II 
pression. Flow cytometry using anti-HLA-DR antibo 
was carried out (Figure 3). Transfectants containing 
plasmid vector pREP4 were used as a negative con 
The class II-negative profile (shaded) of untransfel 
RJ2.2.5 cells is shown for comparison in each pan 
Figure 3. CIITA-8 and CIITA-2.77 clearly shift the FI 
profile to the right and indicate that >90% of the cells 
class II positive. A distinct but small (3- to 5-fold) shi 
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Figure 3. CIITA8, CIITA-2.11, and CIITA-1.23 Can Revert the 
II-Negative Defect in RJ2.2.5 Cells 
Using an anti-HLA-DR antibody, flow cytometry was perform 
RJ2.2.5 cells 4 weeks after stable transfection and selection w 
indicated CllTAcDNAcloneorcontrol pREP4vector DNA. Cell n 
is plotted versus log of relative fluorescence. (A) shows the cl: 
negative FtJ2.2.5 (gray profile) and class II positive Raji (black l 
controls. The pattern of untransfected RJ2.2.5 cells shown in (, 
superimposed on all panels as a gray profile. 
Immunity 
538 
+RTase -RTase 
m1234567m1234567m 
b”l+ 
Figure 4. CIITA-2. II-Derived mRNA Is Pro- 
cessed to the Major RNA Form of C//TA Follow- 
ing Transfection in RJ2.2.5 Cells Allowing Full 
Reversion of the Class II Phenotype 
RT-PCR was carried out on 1 gg of cyto- 
plasmic RNA isolated from the stable C//TA 
transfectants described in Figure 3 using prim- 
ers (5’-TGCCAGCAGAAGTTGGGCA; and 5” 
GGGCCCAGGGAGAAGAGCAGAT) that am- 
plify the endogenous C//TA gene in Raji cells 
and the transfected C//TA gene in RJ2.2.5 cells 
in parallel reactions with (plus) or without (mi- 
nus) reverse transcriptase as indicated. Lane 
1, Raji RNA; lane 2, RJ2.2.5 RNA; lane 3-7, 
RNA from RJ2.2.5 cells transfected with 
pREP4, CIITA-8, CIITA-2. Il. CIITA-IO, and 
CIITA-7.23, respectively. m, 1 kb molecular 
weight ladder. The arrows labeled a and b point 
to the major PCR products that represent CllTA 
and the alternative splice arrangement in 
CIITA-10, respectively. 
class II-positive cells was also observed for transfectants 
carrying C//TA-7.23. CIITA-70 was unable to revert the class 
II-negative phenotype. This was either due to the deletion 
of the serine-, proline-, threonine-rich region, the trunca- 
tion of the protein, or both. Similar results were obtained 
for all clones using an HLA-DQ antibody (data not shown). 
Thus, the expression of CIITA and CllTA clones carrying 
insertions can revert the class II-negative phenotype. The 
finding of stop codons in the inserted sequences of CIITA- 
2.11 and CIITA-1.23 suggests that these sequences are 
removed during reexpression and may be intronic in 
origin. 
To determine whether the extra sequences in CIITA-2.7 7 
and C//TA-7.23 were removed during reexpression, RT- 
PCR assays using primers surrounding the inserted se- 
quences were carried out in each of the stable RJ2.2.5- 
CIITA-transfected cell lines described above. The results 
demonstrated that the major RT-PCR products in Raji 
cells, shown in bands a and b in Figure 4, comigrated 
with the products in CIITA8 and CIITA-10 transfectants, 
respectively (Figure 4, lanes 1,4, and 6). Several RT-PCR 
products, including one equivalent in migration to the 
CIITA-8 product, were observed in the CIITA-2.11 trans- 
fectant (Figure 4, lane 5). Partial sequence analysis of 
this product (Figure 4, lane 5, band a) displayed identity 
to the correctly spliced C//TA product (data not shown), 
indicating that class II expression by transfection of this 
clone is due to the removal of the internal sequence and 
suggests that the sequence is intronic. RT-PCR of RNA 
from C//TA-7.23 transfectants (Figure 4, lane 7) showed 
several bands but no major band at the expected size. 
Unlike CIITA-2.11, CIITA-1.23 does not contain a consen- 
sus 5’ splice donor at the junction of the insert. However, 
a potential splice donor site was located 5 bp inside the 
insert. If this site was used, then in-frame splicing would 
result in the addition of three amino acids, alanine-pro- 
line-serine, to the junction between the domains. If this 
splicing event occurred at a low level, this scenario could 
then explain the partial phenotype reversion that is ob- 
served following transfection of CUTA-1.23 into RJ2.2.5 
cells. 
To determine whether the CIITA-2.77 and CIITA-1.23 
inserted sequences were, in fact, of intronic origin, analyti- 
cal PCR of genomic DNA from Raji cells using primers 
flanking and within the region was carried out. The results 
(Figure 5) showed that the extra sequences in CIITA-2.7 7 
and C//TA-7.23 were indeed intronic but did not comprise 
the entire intron. The 2.7 7 insert, which contains all of 
7.23, is located at the 3’ end of a - 3.2 kb intron (Figure 
5). The data also showed that the first coding exon con- 
tained sequences from the first amino acid to the junc- 
tion at position 596 (Figure 5). Additionally, the sequence 
deleted in CIITA-70 is a separate exon, as primers flank- 
ing the region amplified a -640 bp sequence, indicating 
the presence of a - 490 bp intron between cDNA bp posi- 
tions 743 and 744. Thus, although C//TA cDNA clones 
are derived from both alternatively spliced and aberrantly 
spliced mRNAs, only the CIITA-spliced product can fUttC- 
tionally complement the class II deficiency. 
CIITA Functions Through the X Box Region 
Both the endogenous and transfected conserved class II 
regulatory elements (W, X, and Y) are inactive in RJ2.2.5 
(Riley and Boss, 1993). Even the minimal X box region, 
which functions in Raji cells, is inactive in RJ2.2.5 cells. 
If CIITA functions as a coactivator or a bridging protein, 
then it should be able to direct its activity through the con- 
served sequences of class II MHC genes. To ascertain 
whether the conserved class II regulatory elements could 
function with exogenously provided CIITA and to deter- 
mine the minimal requirements of these elements for class 
II MHC gene expression, a series of cotransfections were 
carried out. Six previously characterized reporter plasmids 
(Riley and Boss, 1993) that contain portions of the HLA- 
DRA conserved regulatory sequences driving a CAT re- 
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Figure 5. Genomic PCR Demonstrates 
the Sequences Contained within CUTA- 
and C//TA-1.23 Are Portions of a Large Ir 
and that the Deletion in CUTA- Is Due t 
Alternatively Spliced Exon 
Raji DNA (50 ng) was amplified with P 
primer pair combinations that would deter1 
the position of exons and introns within 
CllTAgene in the region that displayed altr 
tive cDNA clones. 
(A) The position of the PCR primers are sf 
relative to the CIITA-2.11 cDNA. Primer 
quences are provided in Experimental PI 
dures. 
(B) Agarose gel of PCR reactions with pr 
pairs indicated at the tops of the lanes. 
(C) Schematic representation of the PCI 
suits shows the exonlintron relationship ir 
region of the C//TA gene and the positions c 
intronic sequences in CIITA-2.7 1 and CIITA- 
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porter gene were transiently cotransfected into RJ2.2.5 
cells with CIITA-8, CIITA-70, or the control plasmid pREP4, 
which contained no cDNA insert. The results showed that 
CIITA-8 but not CIITA-10 could support expression of re- 
porter constructions containing the conserved W-X-Y re- 
gion (Table 1). The minimal construction that showed sub- 
stantial activity (-&fold) contained both the Xl and X2 
boxes. Low levels of activation (-2-fold) were seen with 
constructions containing the Xl box alone or the X2 and 
Y boxes when they were cotransfected with CIITA-8. Thus, 
these data support the hypothesis that CIITA functions 
through the X box region. The incremental augmentation 
in expression upon the addition of the Y box to the Xl- 
X2 minimal construction and the doubling of activity i 
the addition of the W box suggests additional interact 
with these factors that may stabilize the activation corn1 
CIITA Contains a Transcriptional Activation Domi 
The above experiments imply that CIITA is part of a c 
plex of proteins that provides the final signal to the b 
transcription machinery for the activation of expres! 
One prediction of this interpretation is that CIITA deli 
the activation signal to the transcriptional machinery 
therefore contains an activation domain. To asce 
whether CIITA contained an activation domain, chin 
GAL4-CIITA fusion vectors were designed and teste 
Table 1. Activation of Class II Regulatory Element-Driven Reporter Genes in Response to Transfected CUTA cDNA Clone Derivatives’ 
Class II-Conserved Regulatory Elements within Reporter Plasmidb 
DNA pDR-G Xl X2-Y Xl-X2 Xl -X2-Y W-X1-X2-Y 
None 
pREP4 
CIITA-8 
CIITA-10 
1 (1 (1 (1 <I *1 
1 <I <l <I (1 <l 
1 2.3 f 0.9 2.7 + 0.6 0.2 f 2.4 12.4 f 1.7 33.3 f 4.2 
1 61 (1 <I (1 (1 
(1, Not detectable above background or less than 1. 
a Mean CAT values f standard error are shown as fold activation over the base vector pDR-G transfected with C//TA cDNA during each experir 
group. 
b CAT reporter plasmids contain the indicated MA-DRA regulatory sequences pG-Xl, pG-X2-Y. pG-X1-X2, pG-X1-X2-Y as well as GALi 
as described (Riley and Boss, 1963). Similar results were obtained for plasmids lacking GAL4 sites. pDR-G contains HtA-DRA sequence 
the Y box (Riley and Boss, 1993). pGloCATwt contains HLA-DRA W-X-Y box elements as described but no GAL4 site (Sloan et al., 1991 
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Figure 6. CIITA Contains a Potent Activation Domain Located in its 
N Terminus 
(A) Schematic representations of GAL4 DNA-binding domain-CIITA 
chimeric plasmids are shown. C//TA fragments were PCR amplified 
and cloned into the GAL4 DNA-binding domain expression vector 
pSG424 as described in Experimental Procedures. GAL4-CUTA plas- 
mids were transiently cotransfected into Raji cells with the pDR-G, 
CA Trepolter gene construction. The data are plotted as the fold activa- 
tion over the expression of the control plasmid pSG424, which ex- 
presses the GAL4 DNA-binding domain only. The average of three 
experiments are shown. Error bars indicate the standard error from 
the mean. 
(8) Schematic representation of GAL4-CIITA constructions within the 
N-terminal 232 aa were used to map the minimal region of full activation 
to the first 125 aa (Students t test between pG-l-1130 and pG-l-125 
was p = 0.14). Experiments were carried out as in (A). 
(C) The N-terminal CIITA activation domain functions in yeast cells. 
Schematic representations of GAL4 DNA-binding domain-CIITA chi- 
merit plasmids constructed in the yeast vector pGBT9 are shown. 
Plasmids were constructed and transformed into yeast cells as de- 
scribed above and in Experimental Procedures. Transformants were 
tested for their ability to activate the his3 and lacZ reporter genes. 
p-galactosidase assays displayed in Miller units are shown. 
their ability to stimulate expression of a minimal reporter 
construction containing a single yeast GAL&binding site 
placed proximal to a basal class II MA-DRA promoter 
lacking the conserved upstream elements. This construct 
had been used before and was shown to be stimulated 
by GAL4-VP16 and GAL4-Ela, but not GAL4-ATF2 or 
GAU-AH chimeric proteins (Riley and Boss, 1993). The 
Table 2. CIITA Inhibits GAL4-VPl6Directed Expression in Raji 
Cells and RJ2.2.5 Cells Transfected with CNTA 
Fold Activation over the Base 
Vector, pDRGAL, Transfected 
with pSG424 DNA 
Cell Line GAL4’ GAL4-VP16 
RajP 8.2 f 0.5 8.6 f 1.0 
RJ2.2.5” 1.36 f 0.3 14.1 f 2.6 
RJ2.2.5 + pREP4 1.07 f 0.1 16.6 f 3.2 
RJ2.2.5 + CIITA-8 7.0 f 0.5 0.3 * 0.5 
n Transfections containing pSG424 DNA, which expresses the GAL4 
DNA-binding domian only; or pSGVP, which expresses the VP1 6 acti- 
vation domain fused to GAL4. 
b Data from previous study Riley and Boss, 1993; shown for com- 
parison. 
constructions shown in Figure 6A represent a series of 3 
end deletions as well as internal segments that were fused 
in frame to the yeast GAL4 DNA-binding domain. The re- 
sults of a transient cotransfection of the pDR-G reporter 
gene and the GAL4-CIITA plasmids into Raji cells indi- 
cated that the entire CllTA gene or any other fusion con- 
struction containing the N-terminal 232 aa was capable 
of activating transcription in this system (Figure 6A). The 
N-terminal half of this region (amino acids l-160) is acidic 
in charge, while the C-terminal half (amino acids 161-232) 
is rich in serines, prolines, and threonines. To determine 
whether this region could be further dissected, additional 
constructions were made and assayed (Figure 6B). The 
minimal region for 36 to 50-fold activation is located be- 
tween amino acids 1 and 125, which is within the acidic 
domain. 5’deletion of this segment to residue 37 reduced 
the activation to - lo-fold, suggesting that a minimal acti- 
vation domain of 89 aa is present between residues 37 and 
125. The serine-, proline-, threonine-rich region in plasmid 
pG-161-232 was not active in this assay. 
To determine the generality of the activation domain and 
to determine in a more sensitive system whether other 
regions of CIITA might also contain activation domains, 
GAL4-CIITA chimeras were tested for their ability to acti- 
vate two yeast promoters. CllTA fragments were sub- 
cloned into the yeast expression vector pGBT9 creating 
GAL4 DNA-binding domain-CIITA chimeras (Figure SC). 
The hybrid constructs were transformed into the HF7c 
yeast strain, which contains two GAL4dependent reporter 
genes, his3 and /acZ. As with the mammalian system, 
strains carrying GAL4-CIITA products containing the 
acidic domain were capable of growing on plates lacking 
histidine (data not shown) and producing j3-galactosidase 
activity (Figure 6C). Thus, the acidic domain on the N ter- 
minus of CIITA can provide an activation domain for class 
II gene expression in mammalian cells and can provide 
an activation function in yeast cells. 
C//TA Expression Results In the Formation of a 
Stable or Higher Order Complex at the X Box 
We showed previously (Riley and Boss, 1993) that the 
presence of the X box region in a reporter construction 
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could interfere with GAL4-VPlbmediated expression in 
Raji but not in RJ2.2.5 cells (Table 2). This interference 
suggested that the factor deficient in RJ2.2.5 was respon- 
sible; and therefore, expression of this factor in RJ2.2.5 
should block GAL4-VP16mediated transcription. To de- 
termine whether CIITA could fulfill this criteria, cotransfec- 
tions were carried out with the CAT reporter construct 
pG(2)-Xl-X2 (contains two helical turns between the GAL4 
site and the Xl box), pSGVP (a plasmid that expresses 
the GAL4-VP16 activation protein), and either pREP4con- 
trol or CIITA-8 DNA. In agreement with the previous re- 
sults, GAL4-VP16 could stimulate expression of an X box 
reporter construction in RJ2.2.5 cells when cotransfected 
with the control pREP4 plasmid (Table 2). However, when 
CUTA- was cotransfected, GAL4-VP16mediated ex- 
pression was not observed. Thus, the expression of CllTA 
in RJ2.2.5 results in a change in the factors assembled 
at the X box region that interferes with VPlB-directed ex- 
pression. 
Discussion 
The cloning of a gene that reverts the class II-negative 
phenotype of the transcriptional mutant cell line RJ2.2.5 
provided a key tool to investigate the mechanism of class 
II MHC gene expression (Steimle et al., 1993). This report 
provides several important pieces of information about 
CIITA and begins to unravel the biological role of CIITA 
in class II MHC gene regulation. Specifically, we have iden- 
tified multiple CllTA transcripts in wild-type B cells; demon- 
strated that CIITAfunctions through the X box region; iden- 
tified a transcriptional activation domain in the N terminus 
of the molecule; and shown that CllTA expression can lead 
to the formation of a higher order complex with X box 
factors. Our results suggest that CIITA may be part of an 
activation complex at class II MHC gene promoters and 
functions as a coactivator or bridging protein. 
The WTA Gene Is Alternatively Spliced 
The major form of CIITA, represented in coding sequence 
by CIITA-8, was capable of restoring class II gene expres- 
sion in RJ2.2.5 cells. The minor form, represented by the 
coding region of CIITA-70, has two major variations that 
are likely to be due to alternative RNA splicing. The first 
removes 49 aa located within a serine-, proline-, threonine- 
rich domain and the second results in a truncated protein 
of only 864 aa instead of 1130 aa. CIITA-70 was not able 
to revert the mutant phenotype of RJ2.2.5. This was ex- 
pected as C-terminal deletions within C//TA reported for 
some of the patient-derived bls cell lines resulted in a class 
II-negative phenotype (Steimle et al., 1993). As CIITA-70 
had multiple changes, a role for the serine-, proline-, threo- 
nine-rich region, which is partially deleted in CIITA-70, can- 
not be ascribed at this time. It is interesting to note that 
overexpression of CIITA-70 in Raji cells did not result in 
a dominant-negative phenotype (J. L. R. and J. M. B., 
unpublished data). This suggests that the portions of CIITA 
that may interact with the class II DNA-binding factors are 
not present in this clone. Moreover, like CIITA, the N-ter- 
minal region in CIITA-10 is fully active in the GAL4 activa- 
tion assay (data not shown). It is, therefore, likely 1 
CIITA-70 does not function either positively or negath 
in class II expression but may function in the express 
of other genes, as it contains a fully functional activa 
domain. 
During the isolation of C//TA cDNAs, clones contair 
portions of intronic sequences were isolated that can CI 
plement the mutation in RJ2.2.5. We showed that car 
ued RNA processing occurred when these incomple 
processed cDNA clones were reexpressed in the nucl 
following DNA-mediated transformation. Because the 
tection of these species was only possible by RT-F 
technology using insert-specific primers, the relative 
quency of this event is probably low. It is, therefore, lil 
that these transcripts are not physiologically relevan 
Activation of Transcription by CHTA 
A single activation domain was found in CIITA, sugges 
a direct role for CIITA in the expression of class II N 
genes. The domain, which is located at the N terminu 
the molecule, was reduced in size to 125 aafor full func 
and can be as small as 89 aa for partial function. . 
region (residues l-l 25) is highly acidic in nature; as 
14 glutamic acid and 10 aspartic acid residues make 
19% of the sequence. In our previous studies, we fo 
that GAL4-VP16 and GAL4-El a, but not GAL4-ATF2 
GAL4-AH chimeric proteins were capable of stimula 
class II promoters (Riley and Boss, 1993). Therefore, 
all acidic activators can activate class II genes; either 
strength of the domain or the specific structure ma! 
responsible for activation. While the original descrip 
of acidic activation domains in yeast suggested that 
acidic nature was the only common factor associated 
a random series of activators (Ma and Ptashne, 19 
experiments on the VP16 activation domain showed 
the acidic nature was not the only important strud 
feature of this domain and that other noncharged ar 
acids played a critical role (Berger et al., 1990). In the ( 
of CIITA, although there is a difference in total net cha 
the percent of acidic residues in the smallest construe 
showing partial activity (23%) is slightly greater than 
percent of acidic residues in the full function domai 
125 residues (19%), suggesting that the overall strut 
of the domain is also important. 
CIITA and%lass II Expression 
The cotransfection of the X box region-driven reps 
vector and C//TA expression plasmids into RJ2.2.5 def 
two cis-acting elements (Xl and X2 boxes) and three 
tors (RFX, X2 box factors, and CIITA) as the minimal 
ments required for class II MHC-specific transcription. 
addition of the Y and W box regulatory sequences ir 
current system and in systems used previously (Riley 
Boss, 1993; Tsang et al., 1966, 1990; Cogswell 81 
1991) augment the expression of the reporter ger 
RJ2.2.5 in a manner that mimics the expression 01 
same reporter constructions in Raji cells (Riley and E 
1993). Thus, the reversion of RJ2.2.5 by CllTA is camp 
Since Steimle et al. (1993) state that CIITA does not i 
act with DNA, the question about how it could functic 
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Figure 7. Models of CIITA Function 
Two models are proposed. 
(A) CIITA directly interacts with the class II-specific DNA-binding fac- 
tors on the DNA. This interaction allows CIITA to use its acidic domain 
to activate the basal transcription machinery. 
(B) CIITA functions upstream of the binding of class II-specific factors 
to DNA. In this example, CIITA functionally modifies RFX to allow it 
to activate transcription of class II genes. 
extremely important. Two simple models are described in 
Figure 7. In model A, CIITA directly interacts with the fac- 
tors bound to the class II-conserved regulatory se- 
quences. Three lines of evidence support this model. First, 
CIITA contains a potent activation domain that was fully 
functional in driving expression of minimal promoters in 
B cells and yeast. Second, the expression of CIITA in cells 
that lack RFX did not revert the class II-negative pheno- 
type (Steimle et al., 1993; Chin et al., 1994), suggesting 
that RFX and CIITA interactions are necessary for activa- 
tion. The third line of evidence comes from both previous 
(Riley and Boss, 1993) and current work in which viral 
activators fused to the GAL4 DNA-binding domain were 
used to probe the interactions at the HLA-DRA promoter 
that contained GAL4 DNA-binding sites in Raji cells, 
RJ2.2.5 cells, and RJ2.2.5 cells transfected with CIITA. 
These experiments demonstrate that the formation of an 
active transcription complex is dependent on CXTA ex- 
pression and support the hypothesis that CIITA is part of 
this complex. However, direct proof of this model awaits 
evidence showing biochemical interactions between RFX, 
X2BP, and CIITA. 
An alternative model, described in Figure 78, depicts 
CIITA functioning upstream of factor binding and control- 
ling class II gene expression by either regulating or modi- 
fying class II-specific factors. In this example, RFX is spe- 
cifically modified. The modification allows RFX to activate 
transcription following binding. If this model were correct, 
then posttranslational differences in RFX or XPBP should 
be observed when comparing Raji and RJ2.2.5 cellular 
extracts. Currently, differences in RFX or XPBP binding 
patterns have not been observed by either electrophoretic 
mobility shift assay (EMSA; Hasegawa et al., 1993; Her- 
rero Sanchez et al., 1992) in vitro DNA methylation inter- 
ference (Hasegawa et al., 1993; Herrero Sanchez et al., 
1992), or in vivo footprinting (Kara and Glimcher, 1991). 
However, subtle modifications of the factors may not be 
detected by these technologies, and therefore this alterna- 
tive model is still plausible. It is interesting to note that in 
vivo DNasel footprinting of the upstream negative regula- 
tory element, the V box, showed occupancy in RJ2.2.5 
but not in Raji cells (Rigaud et al., 1994). One consequence 
of CIITA activity may be to displace factors from this site. 
Many of the interactions and at least part of the order 
of interactions for class II MHCgeneexpression are known 
or can be predicted. In the above models, the documented 
interactions between the class II-specific binding proteins 
are indicated. Vilen et al. (1991), showed that the interac- 
tions between the X and Y box factors was dependent 
on the alignment of the two regions, as full helical turn 
insertions were permitted between the boxes but half turns 
were not. Interactions between X and Y box factors, RFX 
and NFY, were demonstrated both in vitro using EMSAs 
(Reith et al., 1994b) and in vivo by genomic footprinting 
(Wright et al., 1994). Interactions between Xl and X2 box 
factors were suggested by Sloan et al. (1992) using muta- 
tions that specifically knocked out either RFX or XPBP 
binding but still retained more than half of their transcrip 
tional activity. When both mutations were combined, the 
double binding knockout had no transcriptional activity. 
Physical interactions between RFX and X2 box factors 
that enhance the stability of the factors on DNA were also 
described recently (Reith et al., 1994a). 
Clues to the order of binding of factors comes from in 
vivo footprinting of the HLA-DRA locus in both wild-type 
and bls cell lines (Kara and Glimcher, 1991). Bls cell lines 
that lacked RFX binding activity by EMSA were shown to 
have unoccupied or “bare” promoters, while Bls cell lines, 
like RJ2.2.5, which contains RFX binding activity, have a 
fully occupied promoter region. Thus, RFX is likely re- 
quired for nucleation of the factors to the class II promoter 
and may be the first of the MHC class II-specific factors 
to bind. Since all the factors can bind in the absence of 
CIITA, if CIITA does bind, its binding would follow the as- 
sembly of the DNA-binding proteins and serve to stimulate 
transcription through its activation domain. 
Experimental Procedures 
Cells and Cell Culture 
Raji is a B cell line derived from a patient with Burkitt’s lymphoma 
(Epstein et al., 1966). RJ2.2.5 is a MHC class II-negative derivative 
of Raji (Accolla, 1993) and was provided by Dr. R. Accolla(Universityof 
Verona, Italy). Both cell lines were grown in RPM 1540 media (GIBCO, 
Incorporated, Grand Island, New York), supplemented with 5% fetal 
bovine serum (Intergen, Incorporated, Purchase, New York), 5% bo- 
vine calf serum (Hyclone, Incorporated, Logan, Vermont), 2 mM 
L-glutamine, 100 U/ml penicillin, 100 U/ml streptomycin, and 0.25 fre/ 
ml of fungisome (GIBCO, Incorporated, Grand Island, New York). 
Library Screening and C//TA cDNA Clone Analysis 
Approximately 2 x l@ clones of a pREP4 (Invitrogen, Incorporated) 
eukaryotic expression B lymphocyte cDNA library (the library was gen- 
erated from HSC93 B lymphocytes and was provided by Dr. M. Buch- 
wald; The Hospital for Sick Children, Toronto) was transferred to New 
England Nuclear colony/plaque screen filters according to the recom- 
mendation of the manufacturer and screened with three oligonucleo- 
tides specific to WTA coding sequences (B’CTGAAGGATGTGGAA- 
GACCTGGGAAAGC, 5”GATfCCTACACAATGCGTTGCCTGGCTC 
and 5’CAAGGTCCAGCGTGGlTAGTGTCCTCAG). Hybridizations 
were carried out at 5WC in standard hybridization solutions as de 
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scribed previously (Gordon et al., 1992; Sambrcok et al., 1989) and 
washed to a final stringency of 0.5 x SSC and 0.1% SDS. Candidate 
clones (34) were isolated and characterized by hybridization to addi- 
tional CIITA-specific oligonucleotides and by digestion with informative 
restriction enzymes. Full-length clones were completely sequenced 
using dideoxy methods (Sanger et al., 1980). Sequenase T7 DNA 
polymerase (United States Biochemicals), and oligonucleotides spe- 
cific for CUTA. The GenBank accession numbers for CIITA-8, CIITA-10 
and the inserts in CIITA-2.11 and C//TA-7.23 are U18259, U16288, 
U16302, and U16303, respectively. 
Stable Transfectlonr and Flow Cytometry 
CsCI-purified DNA (30 pg) was electroporated into RJ2.2.5 as de- 
scribed (Riley and Boss, 1993). Cells containing plasmid DNA were 
initially selected in 400 U/ml hygromycin B 24 hr later (Calbiochem, 
La Jolla, California). Each week the hygromycin concentration was 
increased by 400 U/ml until a final concentration of 1800 U/ml was 
reached. Stable transfectants (5 x 1Oe cells per sample) were stained 
with phycoerythrinconjugated anti-DR antibodies (Becton Dickinson 
and Company, Mountain View, California) as described previously 
(Skeen and Ziegler, 1993) and analyzed on a FACSort (Becton Dickin- 
son and Company). 
Transient Transfectlons and CAT Assays 
For the CIITA-X box interaction experiments, 20 pg of each CAT re- 
porter construct, 10 cg of each CllTA clone, and 1 ug pSV2Alkphos 
(Yoon et al., 1986) were cotransfected into RJ2.2.5 by electroporation 
as described previously (Riley and Boss, 1993). Transfections involv- 
ing GAL4-VP16 used 20 pg of pSGVP DNA. pSV2Alkphos expresses 
an alkaline phosphatase gene and was used to normalize the transfec- 
tions. Cells were harvested 60-65 hr later, washed, and lysed by three 
rounds of freezing and thawing. CA Texpression was measured by an 
enzyme-linked immunosorbent assay(ELISA) (Boehringer Mannheim, 
Incorporated) using one-third of the extract according to the instruc- 
tions of the manufacturer; 10% of the extract was used in an alkaline 
phosphatase assay (Yoon et al., 1988). To compare the CAT data from 
each transfection, samples were first normalized to the level of the 
alkaline phosphatase activity and expressed as fold activation that 
was derived by dividing the normalized absorbance from each trans- 
fection by the normalized absorbance from the transfection with base 
vector pDR-G in that experiment. The data from three transfections 
were averaged and plotted. The GAL4-CIITA activation assays were 
carried out using a similar procedure with the following differences: 
cotransfections were performed in Raji cells using 20 sg of pDR-G, 
10 pg of the GAL4-CIITA fusion test plasmids, and 1 ug of 
pS&Alkphos. All transfections were normalized as above and fold 
activation was derived by dividing the normalized absorbance of each 
transfection by the absorbance of the pSG424 transfection. 
Plasmld Constructions 
Mammalian vectors expressing GAL4-CIITA fusion proteins were con- 
structed using the pSG424 vector (Sadowski and Ptashne, 1989). In- 
frame PCR products of C//TA generated by amplification with Pful DNA 
polymerase (Stratagene, La Jolla, California) were blunt-end ligated 
into pSG424 DNA that was linearized with BamHl and filled-in with 
the Klenow fragment. CIITA amino acid residues included in these 
constructions are indicated in the name. The following primer pairs 
were used: pG-l-1130,5%AlTCCTACACAATGCGTTGCCTGGCTC 
and 5’CAAGGTCCAGCGTGGTTAGTGTCCTCAG; pG-l-1001, 
5’GAllCCTACACAATGCGTTGCCTGGCTC and 5’ GTCCCCGATC- 
TI’GTTCTCACTC; pG-l-763,5’ GAITCCTACACAATGCGl-fGCCT- 
GGCTC and 57GGAAGATCAGCCCAGCCAGAAAGC; pG-186- 
1001, 5’CCACTGCCTGCGCTGTTCACC and SGTCCCCGATCTT- 
GTTCTCACTC; pG-162-1130, 5’TGAGCCCCCCACTGTGGTGACT 
and S’CAAGGTCCAGCGTGGTTAGTGTCCTCAG; pG-1-232,5%AT- 
TCCTACACAATGCGTTGCCTGGCTC and 57GGTGGGGACAAAG 
TGGATGGG; pG-186-472,5’CCACTGCCTGCGCTGTTCAACC and 
5’GGGCCCAGGGAGAAGAGCAGAT; ~(3-438-763, B’GCTTGTGGC- 
CGGCTTCCCCAGT and 57GGAAGATCAGCCCAGCCAGAAAGC; 
pG-725-1001, 5’AGTGGCGAAATCAAGGACAAGG and 5%TCCCC- 
GATClTGlTCTCACTC; pG-925-1130, B’CTGAAGGATGTGGAAG- 
ACCTGGGAAAGC and 5’CAAGGTCCAGCGTGGTTAGTGTCCT- 
CAG; pG-l-161, 5’GATTCCTACACAATGCGTTGCCTGGCTC and 
5’AGCTGGCTTCCAGTGCTTCAGG; pG-l-125. 5’GATTCCTP 
CAATGCGITGCCTGGCTC and B’TrCATCTGGTCCTATGTG( 
pG-37-125,5’AGCITCTTAACAGCGATGCTG and 5lTCATCTC 
CCTATGTGClT. 
The plasmid pG-1-61 was made by digesting ~0-1-232 with 
and rejoining the ends using the Klenow fragment and T4 DNA lig 
The plasmids pDR-G, pG-Xl, pG-Xl -X2, pG-X2-Y, pG-X1-X2-Y, 
pG(2)-X1-X2, described by Riley and Boss (1993). contain GAL4 I 
binding sites upstream of the indicated class II MHC promoter 
ments. The base plasmid pDR-G contains HLA-DRA promote1 
quences from -61 to +3 but does not contain any of the con98 
upstream elements. The plasmid pGloCATwt contains the W-X-Y 
sequence from HlA-DRA placed upstream of a pglobin promoter 
does not contain a GAL4 site (Sloan et al., 1992). pSG424 (Sado 
and Ptashne, 1989), which expresses the GAL4 DNA-binding do! 
(amino acids i-147), and pSGVP (Sadowski et al., 1968), which 
presses GAL4-VP16 fusion protein, were provided by Dr. M. R. G 
(University of Massachusetts). 
Yeaat Stmlns and Methods 
The HF7c yeast strain is MATa, ura 3-52, his 3-200, ade 2-101 
2-801, trp l-901, leu 2-3,172, gal 4-542, gal 80-538, URA 3:: (c 
l7-mer)3-CXX/acZ, Lys2::GALl-HIS3. (Clontech, Incorporated, 
Alto, California). The cloning vector pGBT9 (Clontech, Incorporc 
replicates in both Escherichia coli and Saccharomyces cerevi! 
carries amp and TRp7 markers, and allows construction and exl 
sion of GAL4 DNA-binding domain fusion proteins. pCL1, which 
codes and expresses the full-length GAL4 protein, was used 
positive control. C//TA DNA fragments shown in Figure 7 were 1 
PCR amplified using primers described above and ligated in fr 
into the BamHl cloning site of pGBT9. HF7c yeast were transform1 
Trp prototrophy with the GAL4-CIITA constructs by the lithium act 
method as described (Schiestl and Gietz, 1989). Colonies were 
sayed for pqalactosidase activity using a filter lift assay (Breedelr 
Nasmyth, 1985). Pqalactosidase activity was quantified using a I 
culture assay (Ausubel et al., 1987). 
PCR 
Genomic PCR reactions were carried out on Raji DNA that was pu 
using a Purogene Genomic Isolation kit (Gentra Systems lncorpor 
Minneapolis, Minnesota) according to the recommendations a 
manufacturer. PCR was performed using 50 ng of genomic DNI 
mM of each primer noted in Figure 6, 0.2 mM dNTPs, 1 U of 
fectMatch (Stratagene, Incorporated, La Jolla, California), and : 
of Taq polymerase (Boehringer Mannheim. Incorporated) in a 
reaction. The DNA was denatured at 94OC for 1 min. primers 
annealed at 58OC for 1 min, and the DNA was extended at 72O 
4 min. This cycle was repeated 35 times. Primers used in Fig1 
areasfollows: primer 1,5’GATlCCTACACAATGCGTTGCCTGG 
primer 2,5’AGCTGGClTCCAGTGClTCAG; primer 3,5’TGCCAl 
GAAGTTGGGCAG; primer 4, B‘CCTACCACCTTCCACAAAC 
primer 5, SGGTTGAACAGCGCAGGCAGTGG; primer 8,5’GGTl 
CAGGGCAGGTGGGC; primer 7, S’ATGTCTCTCCTGACAGAGl 
primer 8, 6’CTCCGTGTGGAGGCCCTAGGGT; primer 9. 5’CC 
GCCTGCGCTGlTCAACC; primer 10, Z’TGGTGGGGACAAAC 
ATGGG. 
RT-PCR was carried out using the RT-PCR kit from Perkin E 
Incorporated, according to the instructions of the manufactun 
the total cytoplasmic RNA isolated by the NP-40 lysis method ( 
brook et al., 1989), 1 pg was used in each sample set. The RN/ 
primed with random hexamers, and the reactions were split ir 
prior to the addition of reverse transcriptase to one-half of the sari 
For the PCR step, samples were heated to 95°C for 2 min and c~ 
to 85OC at which point Taq polymerase was added. PCR cycles 
performed 35 times at 94’C for 1 min, at 60°C for 1 min. and at 
for 1.5 min. Samples were analyzed on a 1.2% agarose gel. 
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